The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
6 marketed package NDCs · 2 active manufacturers
Most dispensed: 10 mg; SULFATE 240 mg · Tablet, Extended Release · #1 blister pack/carton / 10 tablet, extended release in 1 blister pack · 10 mg; SULFATE 240 mg · Tablet, Extended Release · #1 blister pack/carton / 15 tablet, extended release in 1 blister pack · 10 mg; SULFATE 240 mg · Tablet, Extended Release · #10 tablet, extended releases/blister pack · 10 mg; SULFATE 240 mg · Tablet, Extended Release · #15 tablet, extended releases/blister pack
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Every detected change for loratadine and pseudoephedrine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in alpha-Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.